HWAM
KURA icon

Hennion & Walsh Asset Management’s Kura Oncology KURA Stock Holding History

Hennion & Walsh Asset Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.24M Buy
568,845
+233,633
+70% +$2.2M 0.18% 136
2026
Q1 		$2.73M Buy
335,212
+40,407
+14% +$347K 0.09% 281
2025
Q4 		$3.06M Buy
294,805
+79,955
+37% +$839K 0.11% 247
2025
Q3 		$1.9M Buy
214,850
+28,920
+16% +$206K 0.07% 360
2025
Q2 		$1.07M Buy
185,930
+66,114
+55% +$405K 0.04% 479
2025
Q1 		$791K Sell
119,816
-3,099
-3% -$24.1K 0.04% 528
2024
Q4 		$1.07M Sell
122,915
-1,254
-1% -$18K 0.05% 448
2024
Q3 		$2.43M Sell
124,169
-3,450
-3% -$69.9K 0.11% 232
2024
Q2 		$2.63M Sell
127,619
-54,055
-30% -$1.11M 0.14% 200
2024
Q1 		$3.88M Buy
181,674
+54,031
+42% +$1.05M 0.21% 123
2023
Q4 		$1.84M Buy
127,643
+76,943
+152% +$757K 0.1% 258
2023
Q3 		$462K Buy
50,700
+2,013
+4% +$20.4K 0.03% 539
2023
Q2 		$515K Sell
48,687
-1,312
-3% -$15.5K 0.03% 501
2023
Q1 		$611K Sell
49,999
-1,581
-3% -$19.7K 0.04% 463
2022
Q4 		$640K Buy
51,580
+6,430
+14% +$93.5K 0.04% 443
2022
Q3 		$617K Buy
45,150
+11,242
+33% +$173K 0.04% 435
2022
Q2 		$622K Buy
+33,908
New +$488K 0.04% 442

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Hennion & Walsh Asset Management's KURA Position: Q2 2026 in Review

Hennion & Walsh Asset Management increased its Kura Oncology (KURA) stake by 70% in Q2 2026, buying an estimated $2.2M and bringing the position to 568,845 shares worth $6.24M. The position accounts for 0.18% of the portfolio, ranked #136.

Hennion & Walsh Asset Management first reported a position in KURA in Q2 2022 and has held it in 17 quarters since. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Hennion & Walsh Asset Management held 568,845 shares of Kura Oncology worth $6.24M as of Q2 2026.
  • Hennion & Walsh Asset Management bought 233,633 Kura Oncology shares in Q2 2026, an estimated $2.2M.
  • Kura Oncology made up 0.18% of Hennion & Walsh Asset Management's portfolio in Q2 2026, its #136 holding.
  • Hennion & Walsh Asset Management first reported a position in Kura Oncology in Q2 2022 and has held it in 17 quarters since.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.